Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Revenue	$ 9,336	$ 16,329
Operating expenses:
Direct expenses	32,041	27,008
Research and development	180,908	1,710,943
Sales and marketing	898	791,232
General and administrative	581,423	980,381
Impairment of intangibles		367,181
Total operating expenses	795,270	3,876,745
Operating loss	(785,934)	(3,860,416)
Interest expense	(430,039)	(342,516)
Change in fair value of derivative liability	6,688	44,791
Change in fair value of warrant liability	301,402	464,062
Total other (expenses) income	(121,949)	166,337
Loss before provision for income taxes	(907,883)	(3,694,079)
Net loss	$ (907,883)	$ (3,694,079)
Net loss per share- basic and diluted (in Dollars per share)	$ (0.01)	$ (0.03)
Weighted average shares outstanding basic and diluted (in Shares)	111,131,373	111,076,124